Table 1.
Cases | Patient (age (years)/gender) | Distant metastasis | Treatment | Survival/prognostic | Time to relapse |
---|---|---|---|---|---|
Herzberg et al. [9] | 57, female | Kidney | Mastectomy/nephrectomy | 5-year disease-free survival, then lost to follow-up | Distant relapse: 6 years |
Vranic et al. [10] | 76, female | Kidney | Mastectomy/radical nephrectomy | No information after relapse | Distant relapse: 5 years |
Koller et al. [11] | 49, female | Brain, lungs | Breast surgery/Chemotherapy/radiation/left parieto-occipital craniotomy | No relapse at 20 months from the surgery | Local relapse: 1 year. Distant relapse: 8 years |
Silva et al. [12] | 37, female | Brain, liver, lungs, bone | Radical mastectomy/adjuvant chemotherapy (six cycles of adriamycin and cyclophosphamide)/radiotherapy/palliative chemotherapy (docetaxel plus vinorelbine and 5FU in second line) | The patient died 1 year after developing brain metastasis | Distant relapse: 2 years |
Our case | 65, female | Brain, lung, kidney | Mastectomy/palliative chemotherapy (mitoxantrone)/thoracotomy/radical nephrectomy/craniotomy plus radiotherapy | Patient still alive, now presenting liver lesions | Local relapse: 4 years. Distant relapses: 5 years |
5FU 5-fluorouracil